Recent Finacing
Recent Raise
Immunexpress develops SeptiCyte molecular diagnostic assays that quantify immune-response genomic and proteomic markers from whole blood for sepsis diagnosis, triage, severity assessment and point-of-care testing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Immunexpress.
